[go: up one dir, main page]

GB2475701B - A process for the preparation of an orally administered anthelmintic unit dose tablet - Google Patents

A process for the preparation of an orally administered anthelmintic unit dose tablet

Info

Publication number
GB2475701B
GB2475701B GB0920721A GB0920721A GB2475701B GB 2475701 B GB2475701 B GB 2475701B GB 0920721 A GB0920721 A GB 0920721A GB 0920721 A GB0920721 A GB 0920721A GB 2475701 B GB2475701 B GB 2475701B
Authority
GB
United Kingdom
Prior art keywords
preparation
unit dose
orally administered
dose tablet
anthelmintic unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0920721A
Other versions
GB0920721D0 (en
GB2475701A (en
Inventor
Michael Hilary Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB0920721A priority Critical patent/GB2475701B/en
Publication of GB0920721D0 publication Critical patent/GB0920721D0/en
Publication of GB2475701A publication Critical patent/GB2475701A/en
Application granted granted Critical
Publication of GB2475701B publication Critical patent/GB2475701B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0920721A 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet Expired - Fee Related GB2475701B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0920721A GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0920721A GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Publications (3)

Publication Number Publication Date
GB0920721D0 GB0920721D0 (en) 2010-01-13
GB2475701A GB2475701A (en) 2011-06-01
GB2475701B true GB2475701B (en) 2011-10-19

Family

ID=41572721

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0920721A Expired - Fee Related GB2475701B (en) 2009-11-26 2009-11-26 A process for the preparation of an orally administered anthelmintic unit dose tablet

Country Status (1)

Country Link
GB (1) GB2475701B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2848394T3 (en) * 2012-12-19 2021-08-09 Bayer Animal Health Gmbh Tablets that have improved acceptance and good storage stability
DE18837223T1 (en) 2017-07-26 2020-03-26 Tgx Soft Chew, Llc STARCH-FREE SOFT CHEER FOR VETERINARY MEDICAL APPLICATIONS
CN112220769A (en) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 Milbemycin oxime praziquantel flavored tablet and preparation method thereof
CN114306268A (en) * 2021-12-28 2022-04-12 恒诚制药集团淮南有限公司 Praziquantel film coating preparation and preparation method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036069A (en) * 1987-02-19 1991-07-30 Bayer Aktiengesellschaft Anthelmintic active compound combinations
WO2005016356A1 (en) * 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
US20060183766A1 (en) * 2005-02-15 2006-08-17 Wyeth Orally bioavailable CCI-779 formulations
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
WO2008118331A2 (en) * 2007-03-22 2008-10-02 Schering Corporation Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036069A (en) * 1987-02-19 1991-07-30 Bayer Aktiengesellschaft Anthelmintic active compound combinations
WO2005016356A1 (en) * 2003-08-08 2005-02-24 The Hartz Mountain Corporation Improved anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
US20060183766A1 (en) * 2005-02-15 2006-08-17 Wyeth Orally bioavailable CCI-779 formulations
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
WO2008118331A2 (en) * 2007-03-22 2008-10-02 Schering Corporation Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom

Also Published As

Publication number Publication date
GB0920721D0 (en) 2010-01-13
GB2475701A (en) 2011-06-01

Similar Documents

Publication Publication Date Title
IL217034A0 (en) Solid drug tablets for implantable drug delivery devices
EP2429506A4 (en) Coated pharmaceutical capsule dosage form
IL228709A0 (en) Unit dose form for oral administration
IL238477A (en) Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
EP2392307A4 (en) Drug solution dose controller
ZA201304709B (en) A pharmaceutical dosage form
IL216526A (en) Hot-melt extruded pharmaceutical dosage form and a process for manufacture of such pharmaceutical dosage form
EP2665471A2 (en) Controlled release oral pharmaceutical dosage forms comprising mgbg
ZA201105572B (en) Pharmaceutical composition for oral administration
GB2455875B (en) A process for the preparation of an orally administered unit dose tablet
EP2263637A4 (en) Medicinal preparation for oral administration
IL219617A0 (en) Pharmaceutical solid dosage form
IL218643A0 (en) Orally disintegrating pharmaceutical dosage form containing aripiprazole
GB0703674D0 (en) A Process For The Preparation of an Orally Administered Unit Dose Tablet
GB2475701B (en) A process for the preparation of an orally administered anthelmintic unit dose tablet
SI2536396T1 (en) Process for the preparation of oral solid dosage forms comprising valsartan
HU0900482D0 (en) Pharmaceutical formulation for oral administration
HU1000444D0 (en) Process for the preparation of a pharmaceutical active ingredient
HUE040419T2 (en) An analgesic pharmaceutical composition for oral administration
EP2418955A4 (en) High bioavailability oral picoplatin anti-cancer therapy
EP2474294A4 (en) Preparation for oral administration
PL2164468T3 (en) Method for the production of a form of administration of a medicament
GB2437054B (en) A process for the preparation of an orally administered unit dose tablet
AU2007905868A0 (en) Process for the preparation of a solid pharmaceutical dosage form
IL193929A0 (en) A device for orally administering medicine

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20141126